Company intelligence / Profile preview

Second Alpha Partners

New York, New York, United States

Ownership: Private
Development stage: Other

Overview

Second Alpha Partners is a New York-based private investment firm focused on secondary investments in private companies. The firm provides liquidity solutions to founders, executives, venture investors, and other existing shareholders by purchasing shares and convertible securities before an IPO or company sale. Public descriptions of the firm emphasize growth-stage technology and TMT-oriented private companies rather than drug development or healthcare operations. It appears to operate as an investment manager and private equity-style secondary buyer, not as a biotech, pharma, or healthcare company.

Industry: Investors

Beyond the preview

Go deeper on Second Alpha Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Second Alpha Partners.

Explore the full profile